This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a trifluoromethyl group and a spirocyclic framework, makes it valuable for developing pharmaceuticals targeting central nervous system disorders. It is often incorporated into drug candidates to enhance metabolic stability and improve binding affinity to specific receptors. Additionally, it is explored in the design of novel compounds for potential applications in treating psychiatric and neurological conditions, such as depression, anxiety, and schizophrenia. Its unique chemical properties also make it a candidate for research in other therapeutic areas, including inflammation and pain management.